Table of Contents
What changed
AFI's half-year result is a recovery print off a depressed HY21 base. Revenue from operating activities (dividends and distributions received) rose 68.1% to $161.8m, PBT rose 71.6% to $151.2m, and NPAT rose 74.5% to $146.0m. Operating cash flow almost doubled, up 93.9% to $167.5m, and ran ahead of reported NPAT. On the balance sheet, total assets grew 18.2% to $9.562b and equity grew 15.4% to $7.879b, but cash fell to $89.0m from $103.2m and the company now carries $10.0m of bank debt, leaving a net cash position of about $79.0m versus $103.2m previously. The interim dividend is unchanged at 10cps fully franked.
What matters
- Dividend receipts have normalised. The 68.1% rebound in investment income is the single most important driver; it restores payout cover, with the payout ratio against NPAT falling to 83.9% from 145.1% a year earlier. For a listed investment company, that is a meaningful improvement in the sustainability of the current distribution level.
- Distribution was held flat despite the recovery. Management kept the interim at 10cps, the same as HY21, rather than lifting the rate in line with income. Against a backdrop where prior-year cover was well above 100% of NPAT, this looks like a deliberate smoothing choice rather than a constraint.
- Leverage has drifted from net cash toward modest borrowing. Gross borrowings of $10.0m are a new disclosure, and cash fell by $14.2m. The group remains net cash, but the direction is a mild weakening from a very clean prior position.
Expectations
No formal guidance or forward target was provided. The shape context is noisy: HY21 represented only 40.9% of FY21 revenue and 35.6% of FY21 NPAT, so the prior year was heavily second-half weighted as dividends resumed. Annualising HY22 revenue gives roughly $323.5m, about 37.6% above FY21's $235.1m, but this should not be read as a run-rate given the one-off nature of the HY21 compression. The release supports the view that investment income has re-based higher; it does not support a specific full-year figure.
Quality of result
The result looks clean in operating terms. PBT growth of 71.6% is the cleaner read than NPAT growth of 74.6%: the effective tax rate fell to 3.4% from 4.5%, adding roughly 3 percentage points to the NPAT growth rate, but no discontinued operations or non-recurring items were disclosed. Operating cash flow of $167.5m exceeded NPAT, so cash conversion improved rather than deteriorated. That said, this is an investment company and "earnings" are largely dividends received from portfolio holdings — durability depends on the underlying payout policies of investees, not on internal operational leverage. ROE rose to 4.0% from 2.3%, which is a recovery rather than a structural step-change.
Unresolved
- The release excerpts do not disclose NTA per share, so price-to-NTA and the premium/discount position cannot be assessed here.
- Portfolio composition, concentration, and the sources of the dividend recovery by investee are not in the supplied data; the mix between special and ordinary distributions received is also not broken out.
- The reason for introducing $10.0m of bank debt while cash fell $14.2m is not explained in the excerpts.
- Capex and any company-defined free cash flow measure are not disclosed, though these are less relevant for an LIC structure.
This briefing cannot assess the portfolio's current market value, discount or premium to NTA, or any post-balance-date changes in underlying investee dividend policies.
Key metrics
| Metric | HY22 | HY21 | Change |
|---|---|---|---|
| Revenue | $159.4m | $96.2m | +65.7% ↑ |
| Net profit after tax | $146.0m | $83.7m | +74.5% ↑ |
| Net cash inflow from operating activities | $167.5m | $86.4m | +93.9% ↑ |
| Operating profit | $160.7m | $95.2m | +68.8% ↑ |
| Profit before tax | $151.2m | $88.1m | +71.6% ↑ |
| Cash and cash equivalents | $89.0m | $103.2m | -13.8% ↓ |
| Total assets | $9562.4m | $8089.0m | +18.2% ↑ |
Reference: annolyse.ai/briefings/afi-hy22
Analytical metrics
| Metric | HY22 | HY21 | Context |
|---|---|---|---|
| PBT growth | +71.6% | — | cleaner earnings measure |
| Effective tax rate | 3.4% | 4.5% | — |
| Net debt | −$79.0m | −$103.2m | +$24.2m |
| Gross borrowings | $10.0m | — | — |
| Payout ratio vs NPAT | 83.9% | — | — |
| ROE (annualised) | 4.0% | 2.3% | Strengthening |
| HY21 share of FY21 revenue | 40.9% | — | Other half was 59.1% |
| HY21 share of FY21 NPAT | 35.6% | — | Other half was 64.4% |
| Profit from continuing operations | $146.0m | $84.1m | +$61.8m |
Reference: annolyse.ai/briefings/afi-hy22
This analysis was generated using Annolyse, an AI-powered tool that analyses NZX company announcements. The analysis is based on available company filings and standard Annolyse calculations. This is general information only and does not constitute financial advice. The analysis may contain errors. Always read the original company filings and consult a licensed financial adviser before making investment decisions.